Sclerostin is also a key regulator of craniofacial bone morphology, and human mutations inactivating SOST cause sclerosteosis (van Buchem disease), with increased bone mass, mandibular enlargement, and reduced cranial foramen diameter (50). Here, SOST is linked to hyperostosis corticalis generalisata.